F77 Antigen Is a Promising Target for Adoptive T Cell Therapy of Prostate Cancer

0
157
Scientists entailed the generation and evaluation of a second-generation CAR against a carbohydrate antigen on malignant prostate cancer cells.
[Biochemical And Biophysical Research Communications]
Abstract